Publications

Detailed Information

Protective Role of CYP1A1*2A in the Development of Multiple Myeloma

DC Field Value Language
dc.contributor.authorPark, H. K.-
dc.contributor.authorKang, S. H.-
dc.contributor.authorYoon, J. H.-
dc.contributor.authorCho, H. I.-
dc.contributor.authorSuh, C. W.-
dc.contributor.authorLee, D. S.-
dc.contributor.authorLee, J. H.-
dc.contributor.authorYoon, S. S.-
dc.date.accessioned2012-06-27T01:13:27Z-
dc.date.available2012-06-27T01:13:27Z-
dc.date.issued2009-02-
dc.identifier.citationCLINICAL LYMPHOMA & MYELOMA; Vol.9 ; S133-S133ko_KR
dc.identifier.issn1557-9190-
dc.identifier.urihttps://hdl.handle.net/10371/77511-
dc.description.abstractIntroduction and Aims: We had previously reported the association of the N QO1*2/*2 polymorphism with a decreased risk for multiple myeloma (MM) in Koreans (odds ratio [OR], 0.24; 95% CI, 0.01-0.68).ko_KR
dc.language.isoenko_KR
dc.publisherCIG MEDIA GROUP, LPko_KR
dc.titleProtective Role of CYP1A1*2A in the Development of Multiple Myelomako_KR
dc.typeArticleko_KR
dc.citation.journaltitleCLINICAL LYMPHOMA & MYELOMA-
dc.description.tc0-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share